• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可删减区域,椭圆不显著分析的扩展,用于评估二分类结局试验中数据删减的影响。

Region of Attainable Redaction, an extension of Ellipse of Insignificance analysis for gauging impacts of data redaction in dichotomous outcome trials.

机构信息

School of Medicine, Trinity College Dublin, Dublin, Ireland.

School of Physical Sciences, Dublin City University, Dublin, Ireland.

出版信息

Elife. 2024 Jan 29;13:e93050. doi: 10.7554/eLife.93050.

DOI:10.7554/eLife.93050
PMID:38284745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10871715/
Abstract

In biomedical science, it is a reality that many published results do not withstand deeper investigation, and there is growing concern over a replicability crisis in science. Recently, Ellipse of Insignificance (EOI) analysis was introduced as a tool to allow researchers to gauge the robustness of reported results in dichotomous outcome design trials, giving precise deterministic values for the degree of miscoding between events and non-events tolerable simultaneously in both control and experimental arms (Grimes, 2022). While this is useful for situations where potential miscoding might transpire, it does not account for situations where apparently significant findings might result from accidental or deliberate data redaction in either the control or experimental arms of an experiment, or from missing data or systematic redaction. To address these scenarios, we introduce Region of Attainable Redaction (ROAR), a tool that extends EOI analysis to account for situations of potential data redaction. This produces a bounded cubic curve rather than an ellipse, and we outline how this can be used to identify potential redaction through an approach analogous to EOI. Applications are illustrated, and source code, including a web-based implementation that performs EOI and ROAR analysis in tandem for dichotomous outcome trials is provided.

摘要

在生物医学科学中,许多已发表的研究结果经不住更深入的调查,人们对科学领域的可重复性危机越来越关注。最近,引入了无意义椭圆(Ellipse of Insignificance,EOI)分析作为一种工具,使研究人员能够评估二分类结局设计试验中报告结果的稳健性,为同时容忍对照和实验臂中事件和非事件之间编码错误的程度提供精确的确定性值(Grimes,2022)。虽然这对于可能发生潜在编码错误的情况很有用,但它并未考虑到在实验的对照或实验臂中,由于偶然或故意的数据删失,或者由于缺失数据或系统删失,可能导致明显显著发现的情况。为了解决这些情况,我们引入了可达到删失区域(Region of Attainable Redaction,ROAR),这是一种扩展 EOI 分析以考虑潜在数据删失情况的工具。它生成一个有界的立方曲线,而不是椭圆,我们概述了如何通过类似于 EOI 的方法,使用这种方法来识别潜在的删失。本文说明了应用案例,并提供了包括用于二分类结局试验的 EOI 和 ROAR 分析的基于网络的实现的源代码。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2faa/10871715/4f5eacae2f7b/elife-93050-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2faa/10871715/9f3a1ea9ea63/elife-93050-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2faa/10871715/4f5eacae2f7b/elife-93050-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2faa/10871715/9f3a1ea9ea63/elife-93050-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2faa/10871715/4f5eacae2f7b/elife-93050-fig2.jpg

相似文献

1
Region of Attainable Redaction, an extension of Ellipse of Insignificance analysis for gauging impacts of data redaction in dichotomous outcome trials.可删减区域,椭圆不显著分析的扩展,用于评估二分类结局试验中数据删减的影响。
Elife. 2024 Jan 29;13:e93050. doi: 10.7554/eLife.93050.
2
The ellipse of insignificance, a refined fragility index for ascertaining robustness of results in dichotomous outcome trials.无显著性椭圆:一种确定二项结局试验结果稳健性的精细脆弱性指数。
Elife. 2022 Sep 20;11:e79573. doi: 10.7554/eLife.79573.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Implicit Bias and the Association of Redaction of Identifiers With Residency Application Screening Scores.潜在偏见与标识符编校与住院医师申请筛选评分的关联。
JAMA Ophthalmol. 2021 Dec 1;139(12):1274-1282. doi: 10.1001/jamaophthalmol.2021.4323.
5
The new normal? Redaction bias in biomedical science.新常态?生物医学科学中的编辑偏倚。
R Soc Open Sci. 2021 Dec 1;8(12):211308. doi: 10.1098/rsos.211308. eCollection 2021 Dec.
6
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
7
Redaction of sensitive data in the publication of dual use research of concern.在涉及两用研究的出版物中对敏感数据进行编辑。
mBio. 2013 Dec 31;5(1):e00991-13. doi: 10.1128/mBio.00991-13.
8
[Not Available].[无可用内容]。
Therapie. 2010 Mar-Apr;65(2):71-94. doi: 10.2515/therapie/2010006.
9
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
[Informed consent form for biomedical research: a tutorial for redaction].[生物医学研究知情同意书:编辑指南]
Therapie. 2010 Mar-Apr;65(2):71-94. doi: 10.2515/therapie/2010006. Epub 2010 May 19.

引用本文的文献

1
How trustworthy and applicable is the evidence from systematic reviews of depression treatments: Protocol for systematic examination.抑郁症治疗系统评价的证据有多可靠及适用性如何:系统审查方案
PLoS One. 2025 Jun 6;20(6):e0325384. doi: 10.1371/journal.pone.0325384. eCollection 2025.

本文引用的文献

1
Preregistration in practice: A comparison of preregistered and non-preregistered studies in psychology.实践中的预注册:心理学中已预注册和未预注册研究的比较。
Behav Res Methods. 2024 Sep;56(6):5424-5433. doi: 10.3758/s13428-023-02277-0. Epub 2023 Nov 10.
2
The ellipse of insignificance, a refined fragility index for ascertaining robustness of results in dichotomous outcome trials.无显著性椭圆:一种确定二项结局试验结果稳健性的精细脆弱性指数。
Elife. 2022 Sep 20;11:e79573. doi: 10.7554/eLife.79573.
3
Association between Vitamin D Supplementation and Cancer Mortality: A Systematic Review and Meta-Analysis.
维生素D补充与癌症死亡率之间的关联:一项系统评价与荟萃分析
Cancers (Basel). 2022 Jul 30;14(15):3717. doi: 10.3390/cancers14153717.
4
The Fragility of Statistically Significant Results in Randomized Clinical Trials for COVID-19.COVID-19 随机临床试验中统计学显著结果的脆弱性。
JAMA Netw Open. 2022 Mar 1;5(3):e222973. doi: 10.1001/jamanetworkopen.2022.2973.
5
The new normal? Redaction bias in biomedical science.新常态?生物医学科学中的编辑偏倚。
R Soc Open Sci. 2021 Dec 1;8(12):211308. doi: 10.1098/rsos.211308. eCollection 2021 Dec.
6
Challenges for assessing replicability in preclinical cancer biology.评估临床前癌症生物学可重复性面临的挑战。
Elife. 2021 Dec 7;10:e67995. doi: 10.7554/eLife.67995.
7
Fragility indices for only sufficiently likely modifications.仅针对极有可能发生的修饰的脆性指数。
Proc Natl Acad Sci U S A. 2021 Dec 7;118(49). doi: 10.1073/pnas.2105254118.
8
Association between magnetic field exposure and miscarriage risk is not supported by the data.数据不支持磁场暴露与流产风险之间的关联。
Sci Rep. 2021 Nov 12;11(1):22143. doi: 10.1038/s41598-021-01391-3.
9
Comparing dream to reality: an assessment of adherence of the first generation of preregistered studies.比较梦想与现实:对第一代预注册研究的依从性评估
R Soc Open Sci. 2021 Oct 27;8(10):211037. doi: 10.1098/rsos.211037. eCollection 2021 Oct.
10
The fragility index can be used for sample size calculations in clinical trials.脆性指数可用于临床试验的样本量计算。
J Clin Epidemiol. 2021 Nov;139:199-209. doi: 10.1016/j.jclinepi.2021.08.010. Epub 2021 Aug 15.